Well-characterised cancer cell lines are powerful research resources for studying cancer cell biology and for the development of new strategies against cancer. In addition, cancer cell lines which are tumorigenic in athymic nude mice are useful models for testing newly developed anti-tumour agents in vivo.
Many breast cancer cell lines have been established, mainly from the malignant effusions of patients with advanced breast cancer. Such effusions are considered as a good source of viable tumour cells with little contamination by stromal cells, which often interfere with the growth of tumour cells in vitro (Soule, et al., 1973; Calleau et al., 1974; Engel et al., 1978) .
The present report describes the establishment and preliminary characterisation of a new breast cancer cell line, designated KPL-1, which was derived from the malignant pleural effusion of a patient with recurrent breast cancer and has been maintained for over 50 passages. This cell line secretes a large amount of tumour-associated antigens, in particular tissue polypeptide antigen (TPA) (Luning et al., 1980; Bjorklund and Bjorklund, 1983) , and also grows rapidly in female athymic nude mice. TPA has been used as a serum tumour marker for monitoring the clinical course of patients with breast cancer (Nemoto et al., 1979; Mross and Bandlow, 1986; Gion et al., 1990a) . Furthermore, cytosolic TPA in patients with breast cancer has recently been suggested to be of prognostic importance (Gion et al., 1990b) . To investigate the kinetics of tumour-associated antigens, the secretion of TPA and CA 15-3 (Kufe et al., 1984; Hayes et al., 1986; Abe and Kufe, 1987) was measured through cell growth phases in this cell line.
Materials and methods
Patient and cell culture A 50-year-old Japanese woman with a primary breast cancer underwent a modified radical mastectomy in March 1989. The histological diagnosis of the resected specimen was invasive ductal carcinoma of the breast with a predominant Correspondence: J Kurebayashi Received 2 September 1994; revised 17 November 1994; accepted 22 November 1994 intraductal component and multiple axillary lymph node metastases. Several supraclavicular lymph node metastases were observed in June 1991. The patient received a combined therapy including chemoendocrine therapy and radiation therapy from June 1991 to January 1993. The recurrent disease progressed-with little response to these therapies, and the patient died of breast cancer in February 1993. An autopsy revealed the recurrent disease in the skin, supraclavicular and mediastinal lymph nodes, vertebral bones, thyroid gland, pleura and liver.
Malignant pleural fluid was obtained from the patient in December 1992. A 50 ml volume of the heparinised fluid was centrifuged at 150 g for 10 min. Then the supernatant was removed and the cell pellet was resuspended and plated in T-25 flasks (Corning Japan, Tokyo, Japan) containing Dulbecco's modified essential medium (DMEM) (ICN Biochemicals, Costa Mesa, CA, USA) supplemented with 10% fetal bovine serum (FBS) (ICN Biochemicals Japan, Osaka, Japan). Serial passages using 0.05% trypsin (Difco, Detroit, MI, USA) in phosphate-buffered saline (PBS) were done once or twice a week. No additional supplements such as oestradiol, insulin or antibiotics were needed for stable growth of the KPL-1 cells. Since atypical epithelial cells predominantly grew in culture during all of the passages and cytogenetic analysis as described below strongly indicated that the cells are of monoclonal origin, we have not attempted to subclone them.
Morphological analysis
Haematoxylin-eosin staining of paraffin-embedded specimens was performed using the conventional method in the original tumour of the patient, the recurrent tumour which was obtained in the autopsy and KPL-1 tumours transplanted into nude mice. Five per cent buffered-formalin was used as the fixative. Cytological examination of pleural effusion obtained from the patient was also performed. After centrifugation of the effusion at 150 g for 5 min, smears were made from the cell deposit onto a glass slide. The smears were stained by the conventional Papanicolaou's method. Photographs were obtained with an Olympus AH-2 microscope (Olympus, Tokyo, Japan).
Cultured KPL-1 cells in a T-25 flask were observed and phase-contrast microphotographs taken with an inverted Nikon Diaphot-TMD microscope (Nikon, Tokyo, Japan).
For transmission electron microscopy, KPL-1 tumours that had been transplanted into nude mice were resected, minced into 1 mm in size and fixed with 2.5% glutaraldehyde (Sigma, St Louis, MO, USA) in PBS for 2 h at 4°C. After washing with PBS, the blocks were post-fixed with 1% osmium tetroxide in 0.1 M cacodylate buffer and embedded in epoxy resin. These were cut into thin sections with a Supernova ultracutter (Reichert-Jung, Wien, Austria) with a diamond knife, stained with uranyl acetate and lead citrate, and examined with a Hitachi H-7100 electron microscope (Hitachi Electronics, Tokyo, Japan).
For immunohistochemical study, paraffin sections of the tumour samples were dewaxed in xylene, hydrated with PBS, treated with hydrogen peroxide for elimination of endogenous peroxidase and then processed by the immunoperoxidase procedure. A rabbit anti-cytokeratin (Milab, Tokyo, Japan), anti-CEA (Milab), anti-CA 15-3 (Turner, Tokyo, Japan), anti-vimentin (Dako Japan, Tokyo, Japan) and antierbB-2 oncoprotein (Triton Biosciences, Alameda, CA, USA) were used as the first antibodies. Control experiments were performed by substituting normal serum for the first a antibodies. The reaction was visualised by streptavidin-biotin (Nichirei, Tokyo, Japan) ['25l17p-oestradiol and ['25I]R5020 (New England Nuclear, Boston, MA, USA) as the respective ligands as described previously (Kurebayashi et al., 1990) . Epidermal growth factor receptor (EGFR) in membrane fractions of the tumours was determined by a radioreceptor assay using ['25I]EGF (New England Nuclear) as the ligand as described by Yasui et al. (1988) .
Oncogene amplification Total cellular DNA was extracted by a conventional phenolchloroform method. DNA dot-blot hybridisation was performed as described by Kinoshita et al. (1993) . DNA samples were spotted onto Hybond N nylon sheets (Amersham, Arlington Heights, IL, USA) using a Hybri-dot blotting manifold (BRL, Bethesda, MD, USA). The sheets were then hybridised with 32P-labelled specific DNA probes and exposed to X-ray films. Hybridisation signals were analysed with a BSA2000 bioimaging analyser (Fuji Film, Tokyo, Japan). The degree of oncogene amplification was estimated by comparison with the radioactivity of placental DNA on the same membrane. The actin probe was used as an internal control for determination of the amount of DNA in each dot on the membrane. The DNA probes were a 1.6 kb EcoRI fragment of human erbB-2, a 1.8 kb fragment of the EcoRI-Clal third exon fragment of c-myc, a 3.7 kb Sacl fragment of H-ras and a 2.0 kb fragment of the PvuII fragment of N-ras. All DNA probes were obtained from Otsuka Pharmaceutical (Tokushima, Japan). Cell growth in vitro and in vivo Approximately 1 x 105 cells per well were plated in 12-well plates (SB Medical, Tokyo, Japan) and grown in DMEM supplemented with 10% FBS for two weeks at 37°C in a 5% carbon dioxide atmosphere. Triplicate wells were trypsinised at the times indicated and the viable cells were counted in a haemocytometer using trypan blue exclusion. The tumour doubling time in vitro was estimated from the linear portion of the growth curve.
To investigate the oestrogen-responsiveness of the KPL-1 cells in vitro, 1 x IO0 cells per well were plated in the 12-well plates and grown in phenol red-free RPMI-1640 medium (Gibco BRL, Tokyo, Japan) supplemented with 2% dextrancoated charcoal treated-FBS (Scholl et al., 1983) at 37°C in a 5% carbon dioxide atmosphere. 17P-Oestradiol 1 x 10-6 M (E2, Sigma) and tamoxifen 1 x 10-4 M (TAM, Zeneca Pharmaceuticals, Macclesfield, UK) were prepared as concentrated stocks in 100% ethanol and diluted 1:1000 (v/v) into the culture medium. The final ethanol concentrations was 0.1%. At this concentration the vehicle did not alter the growth of the KPL-1 cells. The culture medium was changed every other day. Triplicated wells were trypsinised 7 days after the cell inoculations and the viable cells were counted in a haemocytometer using trypan blue exclusion.
Semiconfluent KPL-1 cells were trypsinised and harvested. Viable cells were counted in a haemocytometer using trypan blue exclusion and centrifuged. Cell pellets were resuspended with medium and the cell density was adjusted to the desired level. Then 1 x, 5 x and 10 x 106 viable cells/0.2 ml of the medium were injected into the mammary fat pad (two injections per mouse) of 4-to 6-week-old Balb/c nu/nu female athymic nude mice (Clea Japan, Tokyo, Japan). Tumour volume was calculated as the product of the largest diameter, the orthogonal measurement and the tumour depth. Mean tumour volume was calculated as the sum of tumour volumes divided by the number of tumours.
Measurement of tumour-associated antigens TPA was measured in serum of the patient and nude mice transplanted with the KPL-1 cells, pleural effusion and medium by an RIA kit (AB Sangtec Medical, Bromma, Sweden), CA 15-3 by an RIA kit (Centcor, Malven, PA, USA), and CEA by an enzyme immunoassay kit (Dinabot, Tokyo, Japan). The coefficients of intra-and inter-assay variations were not higher than 10.8% for all the three marker levels (data not shown).
The concentration of these antigens in KPL-1 tumours resected from nude mice was also measured as follows: 0.2 g of each tumour was homogenised by a Polytron homogeniser with 2.0 ml of saline and the concentration of the antigens in the supernatant was measured by the same method as described above.
To estimate the amount of secretion of TPA and CA 15-3 from the KPL-1 cells, the cells were washed twice with PBS after removal of medium. Then fresh medium was added, and the cells were incubated for a day. Next, the medium was collected and the concentrations of TPA and CA 15-3 in the medium were measured by the same method as described above. Because the concentration of these tumour-associated antigens in the fresh medium was undetectable and the antigenicities were stable for at least a day (data not shown), the secretion per cell per day was calculated as follows:
Secretion per cell per day = concentration of each marker x volume of medium mean cell number Histological examination of the KPL-1 tumours transplanted into nude mice revealed that relatively demarcated tumours had formed in the subcutaneous tissue of the nude mice and showed expansive growth. Numerous small nests of tumour cells were recognised and small lumina were found among the tumour cells. Each tumour cell had a round or oval-shaped nucleus with a large nucleolus, and small intracytoplasmic lumina were often found (Figure le) . These findings were similar to those observed in both original and metastatic tumours of the patient. Ultrastructurally, a large oval nucleus with a large nucleolus and prominent chromatin was seen in the KPL-1 tumour cells transplanted into nude mice. In the cytoplasm, many mitochondria and well-developed rough endoplasmic reticulum were recognised. Large intracytoplasmic lumina with protruding microvilli were often found in the tumour cells (Figure 2a ). In addition, numerous intermediate filaments distributed in the cytoplasm and junctional structures (desmosomes) among the tumour cells were recognised (Figure 2b) . Immunohistochemical (Figure 3a-c) . Interestingly, these findings were also observed in the original tumour of the patient (Figure 3d-f) .
Karyotype analysis A total of 40 cells from the KPL-1 cell line at the 24th passage were studied, and a detailed analysis by the trypsin-Giemsa method was performed in ten metaphases. A histogram of the chromosome number indicated a median of 78 with a range from 74 to 80 (Figure 4 ). When G-banding was performed, 17-25 marker chromosomes were found. The common aberrations were 2q +, 3p +, Sq +, 6q +, 7p+, 8p+, 9p+, 10p+, 19q+, 22p+ and Xq+ in all ten metaphases. Normal human chromosomes were identified; they included numbers 1, 17, 18 and 21. Chromsome number 20 was not identified ( Figure 5 ). These findings strongly suggest that this cell line is derived from a monoclonal human cancer cell.
Receptor analysis and gene amplification brane fraction with a dissociation constant of 3.5 ± 1.9 x 10-9 M (mean ± s.d., n = 3), was detected in the transplanted tumours.
No gene amplification of c-erbB-2, c-myc, H-ras and N-ras measured by DNA dot-blot hybridisation was seen in the transplanted KPL-1 tumours. The estimated copy number of the genes in KPL-1 cells was 0.92 for c-erbB-2, 0.98 for c-myc, 1.08 for H-ras and 1.12 for N-ras.
Cell growth in vitro and in vivo An anchorage-dependent growth curve at the 24th passage is shown in Figure 6 . The population -doubling time was approximately 48 h when the cells exponentially grew in DMEM supplemented with 10% FBS.
As shown in Figure 7 , the addition of 10-9 M E2 alone, I07-M tamoxifen alone or both of them into the E2-deficient medium as described above did not alter the anchoragedependent growth of the KPL-1 cells. Similar results were obtained in three separate experiments.
KPL-1 cells at the 5th, 21st, 25th and 42nd passages were injected into the mammary fat pads of female athymic nude mice. The cells from all the passages developed tumours in the nude mice at a take rate of 100% (4/4 for the 5th passage, 10/10 for the 21st passage, 18/18 for the 25th passage and 12/12 for the 42nd passage). When 1 x 106 cells were injected into the mice at the 25th passage, tumours could be detected 2 weeks after the injections. In contrast, when 5 x or 10 x 106 cells were injected, tumours developed within a week after the injections and grew rapidly, as shown in Figure 8a . To confirm the stable tumorigenicity of the KPL-1 cells in the nude mice, 5 x 106 cells were also injected into female nude mice at the 42nd passage. Tumours developed within a week after the injections and grew rapidly, as shown in Figure 8b .
Post-mortem examination revealed that the tumours were basically well circumscribed, and no macroscopic metastasis was observed in the lymph nodes, lungs, liver or kidney.
Representative sections cut from paraffin-embedded specimens of the explored organs were stained with haematoxylineosin and observed with a light microscope. During the experiment using KPL-1 cells at the 24th passage, only three microscopic metastatic foci (5.6%) were observed at the periphery of lymph nodes in 54 explored lymph nodes 6 weeks after the cell injections. No metastasis was found in the lungs, liver or kidney of the nude mice. During the experiment using KPL-1 cells at the 42nd passage, four microscopic metastatic foci were observed at both the periphery and the centre of lymph nodes (33.3%) in 12 explored lymph nodes 9 weeks after the cell injections ( Figure  9a and b) . Again, no distant metastasis was found. Secretion of tumour-associated antigens Three tumour-associated antigens, TPA, CA 15-3 and CEA, were measured in the serum and pleural effusion of the patient and medium collected from KPL-1 cells cultured in a T-25 flask for 7 days. As shown in Table I , an extremely high concentration of TPA was found in all the samples. The concentration of TPA in the medium was approximately ten times higher than that in the pleural effusion. In contrast, the concentrations of CA 15-3 and CEA in the medium were, respectively, approximately 50 times and seven times lower than those in the pleural effusion.
To confirm the production of these tumour-associated antigens from the KPL-1 cells, the antigens were measured in the supernatant of homogenised KPL-1 tumours resected from the nude mice. The concentrations of TPA, CA 15-3 and CEA were 12 000 U, 6000 U and 2800 ng g' wet tissue respectively. Immunohistochemistry using anti-CA 15-3 and anti-CEA antibody also showed the presence of CA 15-3 and CEA in the transplanted KPL-1 tumours, as described above (Figure 2b and c) .
To investigate the relationship between the secretion of tumour-associated antigens and the cell growth phase, the production of the antigens per cell per day was calculated as described in Materials and methods at each cell growth phase including the lag phase, the exponential growth phase and the plateau phase. Interestingly, TPA secretion from KPL-1 cells rapidly increased during the exponential growth phase and sharply decreased during the plateau phase, but CA 15-3 secretion was constant throughout the cell growth phases (Figure 6 ). The TPA secretion -during the exponential phase was significantly larger than that during the lag phase or that during the plateau phase (P<0. To study the secretion of TPA from KPL-1 cells in vivo, serum of the nude mice into which KPL-l cells had been transplanted was collected and the TPA concentration in the serum was measured. Interestingly, serum TPA was significantly related to the volume of transplanted tumours with a correlation coefficient of 0.90 for 25th passage and 0.88 for 42nd passage, as shown in Figure lOa and b. aThe concentration of each tumour-associated antigen was measured as described in Materials and methods. bThe normal range of each serum tumour marker is less than 2.5 ng ml-' for CEA, less than 30 U ml-I for CA 15-3 and less than 110 U 1-l for TPA according to the manufacturer's recommendations. cThe medium was collected from a 7 day culture of KPL-I cells in a 12-well dish. The final cell density was approximately half a million cells per ml. sacrificed 9 weeks after the injections and blood was collected. Serum TPA levels were measured as described in Materials and methods. These levels linearly rose as the tumours grew.
Discussion
Breast cancer cell lines such as the MCF-7 cell line (Soule et al., 1973) have contributed greatly to the understanding of breast cancer cell biology and the development of new therapeutic approaches for breast cancer. However, there is a remarkable heterogeneity among human breast cancers in terms of hormone responsiveness and genetic alterations (Wolman and Dawson, 1991; Chen et al., 1992; Horwitz, 1992) . For these reasons, the establishment of new and wellcharacterised breast cancer cell lines is important.
To confirm that KPL-1 cells were derived from human breast cancer cells, morphological analysis with light and electron microscope and cytogenetic, immunohistochemical and biochemical analyses were conducted. All these data suggested that KPL-1 cells are of epithelial origin and may be derived from breast cancer. Furthermore, large amounts of tumour-associated antigens, CEA, CA 15-3 and TPA, were detected in the serum and pleural effusion of the patient. Both the secretion of these antigens from these KPL-1 cells into medium and positive immunoreaction for CA and CEA in the cells suggested that they originated from the same tumour cells of the patient (Table I and Figure 3) . KPL-1 cells in culture seem to secrete much more TPA than CA 15-3 or CEA. Although it might be possible that the metabolism of CA 15-3 and CEA in pleural effusion and blood circulation differs from that in culture medium, it is likely that KPL-1 cells preferentially secrete TPA in an anchorage-dependent culture condition. Further experiments are needed to clarify and understand this phenomenon.
TPA is a protein antigen composed of more than 200 amino acids with a molecular weight of 17-43 kDa (Luning et al., 1980) . This protein is suggested to be related to non-epidermal keratins 8, 18 and 19 (Weber et al., 1984) . Production and secretion of TPA from cultured HeLa cells has been reported to correlate with the early S-phase and the mitotic phase respectively (Bjorklund and Bjorklund, 1983) . Thus, TPA is thought to be related to proliferative activity in general. TPA has been found not only in a variety of human malignancies, including breast cancer, but also in rapidly growing normal organs such as fetal tissues (Bjorklund and Bj6rklund, 1983) . Accumulated knowledge of TPA indicates that TPA may be a unique tumour-associated antigen in malignancies and also may be related to the regulatory mechanisms of cell growth. Preliminary results in the present study suggested that KPL-1 cells secrete a larger amount of TPA during the exponential growth phase than during the lag phase or the plateau phase. In contrast, the secretion of CA 15-3 seemed to be independent of any cell growth phase. Further analysis of KPL-1 cells, including the relationship between the cell cycle and secretion or production of tumourassociated antigens, should be done. Interestingly, the serum TPA concentration could be measured in the nude mice into which KPL-1 cells had been transplanted and the concentration linearly correlated with the volume of transplanted tumours (Figure 10 ). To the best of our knowledge, KPL-1 is the first cell line in which serum TPA has been detected in vivo. This cell line may make it possible to study the kinetics of tumour markers in vivo as well as in vitro.
It is known that breast cancer cell lines tend to be less tumorigenic and less metastatic than other cancer cell lines derived from lung, renal and colon carcinomas and sarcomas when the cell lines are subcutaneously injected into the flank of nude mice (Ozzello and Sordat, 1980; Shafie and Liotta, 1980; Price et al., 1990) . Recent reports suggest that orthotropic transplantation of cancer cell lines into nude mice is more tumorigenic and sometimes induces spontaneous metastasis (Fidler, 1991) . In the present study, KPL-1 cells were injected orthotropically into the mammary fat pads of female nude mice. The tumour take rate of KPL-l cells by this orthotropic transplantation was 100% and all the transplanted tumours grew rapidly (Figure 8) . Moreover, micrometastases into the lymph nodes could be recognised in the nude mice with transplanted KPL-1 cells (Figure 9 ). These findings support the suggestion that orthotropic transplantation of cancer cell lines may be useful in creating tumours and spontaneous metastasis in nude mice. (Murphy and Dotzlaw, 1989; Wang and Miksicek, 1991; Fuqua et al., 1992 (Soule and McGrath, 1980) . This fact suggests that KPL-1 cells may grow oestrogen independently in female nude mice or that a low level of endogenous oestradiol may be sufficient to make KPL-1 cells grow in female nude mice. To address these questions, animal experiments using ovariectomised nude mice are underway.
Recently, some variants of the MCF-7 cell line have been reported to be ER positive but grow oestrogen independently in nude mice (Gottardis and Jordan, 1988; Clarke et al., 1989; McLeskey et al., 1993) . One of these variants, the MKS-1 cell line, which overexpresses fibroblast growth factor 4, has been reported to show rapid growth in ovariectomised nude mice and maintain the expression of ER (McLeskey et al., 1993) . These 
